Literature DB >> 34738177

Rational design and synthesis of modified natural peptides from Boana pulchella (anura) as acetylcholinesterase inhibitors and antioxidants.

Ivan Sanchis1,2, Roque Spinelli1,2, Nicolas Aschemacher1, Alvaro Sebastían Siano3,4.   

Abstract

The use of acetylcholinesterase (AChE) inhibitors, antioxidants or multitarget compounds are among the main strategies against Alzheimer's disease (AD). Between AChE inhibitors, those targeting the peripheral anionic site (PAS) are of special interest. Here, we describe the rational design and synthesis of peptide analogs of a natural PAS-targeting sequence that we recently discovered, aiming at increasing its activity against AChE. We also tested their radical scavenging and metal chelating properties. Our design strategy was based on the position-specific, computer-aided insertion of aromatic residues. The analog named as W3 showed a 30-fold higher inhibitory activity than the original sequence and an improved antioxidant activity. W3 is the most potent modified natural peptide against Electrophorus electricus AChE ever reported with an IC50 of 10.42 μM (± 1.02). In addition, it showed a radical scavenging activity of 47.00% ± 3.11 at 50 μM and 93.47% ± 1.53 at 400 μM. Since peptides are receiving increasing interest as drugs, we propose the W3 analog as an attractive sequence for the development of new peptide-based multitarget drugs for AD. Besides, this work sheds light on the importance of the aromatic residues in the modulation of AChE activity and their effect on the radical scavenging activity of a peptide.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Drug design; Inhibitors; Peptides

Mesh:

Substances:

Year:  2021        PMID: 34738177     DOI: 10.1007/s00726-021-03096-3

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  48 in total

1.  HADDOCK: a protein-protein docking approach based on biochemical or biophysical information.

Authors:  Cyril Dominguez; Rolf Boelens; Alexandre M J J Bonvin
Journal:  J Am Chem Soc       Date:  2003-02-19       Impact factor: 15.419

2.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

3.  Electrostatic control of aromatic stacking interactions.

Authors:  Scott L Cockroft; Christopher A Hunter; Kevin R Lawson; Julie Perkins; Christopher J Urch
Journal:  J Am Chem Soc       Date:  2005-06-22       Impact factor: 15.419

Review 4.  From combinations to multitarget-directed ligands: A continuum in Alzheimer's disease polypharmacology.

Authors:  Claudia Albertini; Alessandra Salerno; Pedro de Sena Murteira Pinheiro; Maria L Bolognesi
Journal:  Med Res Rev       Date:  2020-06-19       Impact factor: 12.944

5.  Purification, identification and characterization of two novel antioxidant peptides from finger millet (Eleusine coracana) protein hydrolysate.

Authors:  Himani Agrawal; Robin Joshi; Mahesh Gupta
Journal:  Food Res Int       Date:  2018-11-16       Impact factor: 6.475

6.  Discovery of a New Donepezil-like Acetylcholinesterase Inhibitor for Targeting Alzheimer's Disease: Computational Studies with Biological Validation.

Authors:  Bashir Akhlaq Akhoon; Sushil Choudhary; Harshita Tiwari; Ajay Kumar; Manas Ranjan Barik; Laxmi Rathor; Rakesh Pandey; Amit Nargotra
Journal:  J Chem Inf Model       Date:  2020-10-08       Impact factor: 4.956

7.  Acetylcholinesterase inhibitors with photoswitchable inhibition of β-amyloid aggregation.

Authors:  Xinyu Chen; Sarah Wehle; Natascha Kuzmanovic; Benjamin Merget; Ulrike Holzgrabe; Burkhard König; Christoph A Sotriffer; Michael Decker
Journal:  ACS Chem Neurosci       Date:  2014-03-14       Impact factor: 4.418

Review 8.  Oxidative stress in Alzheimer's disease.

Authors:  Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

Review 9.  Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy.

Authors:  Thaiane Coelho Dos Santos; Thaís Mota Gomes; Bruno Araújo Serra Pinto; Adriana Leandro Camara; Antonio Marcus de Andrade Paes
Journal:  Front Pharmacol       Date:  2018-10-18       Impact factor: 5.988

Review 10.  Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Authors:  Youssef H El-Hayek; Ryan E Wiley; Charles P Khoury; Ritesh P Daya; Clive Ballard; Alison R Evans; Michael Karran; José Luis Molinuevo; Matthew Norton; Alireza Atri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.